Spur Therapeutics today announced positive feedback from its end-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA), supporting its planned Phase 3 trial for FLT201, an ...

HGH production declines over time, with an even sharper drop for women going through menopause, according to a study in the ...